ARRDC3 and esophageal squamous cell carcinoma: Hence, the main objective of the study was to test this hypothesis and to explore the mechanisms by which miR-624 might increase chemotherapy resistance of ESCC cells through regulation of the ARRDC3/YAP/HIF1α signaling axis.